Clinical Trial Update: A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men [Phase 1]

View source ↗

Summary

Phase 1 study assessing the drug interaction between valproic acid and a single dose of paliperidone extended-release in healthy men; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Epilepsy | Phase 1 | Status: COMPLETED